ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag drug development pharma fda industry cancer

Lazarus Drugs
Kate Yandell | Feb 1, 2015 | 8 min read
While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.
 
23andMe Enters Drug Development
Kerry Grens | Mar 12, 2015 | 2 min read
The personal genomics firm announces plans to make medicines.
Matthew Disney
A Quest to Drug RNA
Ida Emilie Steinmark, PhD | Sep 8, 2023 | 5 min read
Matthew Disney’s idea of small molecules that target RNA once seemed fanciful. Now, even the pharma industry is pursuing it
FDA Gives Nod to Melanoma Drug
Jef Akst | Sep 8, 2014 | 2 min read
The US Food and Drug Administration last week approved the first of a new type of immunotherapy that aims to pit a patient’s own immune system against her cancer.
Bugs as Drugs to Boost Cancer Therapy
Danielle Gerhard, PhD | Jan 18, 2024 | 7 min read
Bioengineered bacteria sneak past solid tumor defenses to guide CAR T cells’ attacks.
Gilead to Pay Nearly $12B for CAR T-Cell Company
Jef Akst | Aug 28, 2017 | 2 min read
The massive sum will buy out Kite Pharma, whose cancer therapy is expected to be among the first of its type approved by the FDA.
Industry Applauds FDA Plan For Faster Cancer-Drug Review
Steven Benowitz | Apr 28, 1996 | 8 min read
Review But many critics are urging still other changes, including easier approval of 'off-label' uses DÉJÀ VU: NCI's David Parkinson sees parallels with AIDS drug testing. By Oncologists, industry officials, and cancer-patient advocacy organizations are applauding recently announced policy changes at the Food and Drug Administration (FDA) that speed up the approval process for cancer drugs. The plan, announced on March 29 by President Bill Clinton, aims to immediately streamlin
Obama Signs FDA Bill
Bob Grant | Jul 11, 2012 | 2 min read
The new law reauthorizes fees charged to drug and device makers, creates new fees for the approval of generic drugs.
Concerns over Efficacy and Cost of Muscle Wasting Treatments
Ruth Williams | Nov 11, 2020 | 5 min read
Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.
Picking Up the Pace
Kate Yandell | Jan 1, 2016 | 10 min read
FDA designations promise to expedite the approval of drugs for conditions ranging from infectious disease to cancer.

Run a Search

ADVERTISEMENT